CIK 0001626878 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in A1 · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Net income (USD) | -32.9 M | -17.4 M | ||
| Diluted EPS (USD/shares) | -1.49 | -0.81 | -1.08 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | ARS | ARS | 2026-10-02 |
| 2026-10-02 | DEF 14A | FORM DEF 14A | 2026-11-24 |
| 2026-08-13 | 10-Q | FORM 10-Q | 2026-06-30 |
| 2026-05-14 | 10-Q | FORM 10-Q | 2026-03-31 |
| 2026-04-29 | 10-K/A | FORM 10-K/A | 2025-12-31 |
| 2026-03-13 | 10-K | FORM 10-K | 2025-12-31 |
| 2026-03-11 | S-8 | FORM S-8 | |
| 2026-01-23 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-01-23 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2025-12-09 | 8-K | FORM 8-K items 5.02 | 2025-12-05 |
| 2025-11-12 | 10-Q | FORM 10-Q | 2025-09-30 |
| 2025-11-12 | 4 | 4 | 2025-10-01 |
| 2025-11-12 | 4 | 4 | 2025-10-01 |
| 2025-11-12 | 4 | 4 | 2025-10-01 |
| 2025-11-12 | 4 | 4 | 2025-10-01 |
| 2025-10-15 | 8-K/A | FORM 8-K/A items 5.02 | 2025-06-24 |
| 2025-10-03 | 8-K | FORM 8-K items 1.01,5.02,9.01 | 2025-10-01 |
| 2025-09-30 | 3 | 3 | 2025-08-29 |
| 2025-09-30 | 3 | 3 | 2025-08-29 |
| 2025-09-29 | 3 | 3 | 2025-08-29 |
| 2025-09-16 | 3 | 3 | 2025-08-29 |
| 2025-09-02 | 8-K | FORM 8-K items 5.07 | 2025-08-29 |
| 2025-08-13 | 10-Q | FORM 10-Q | 2025-06-30 |
| 2025-07-07 | ARS | ARS | 2024-12-31 |
| 2025-07-07 | DEF 14A | DEF 14A | 2025-08-29 |
Forms on file (last 1,000): 4 127, 8-K 58, 10-Q 35, 3 26, SC 13G/A 22, 4/A 16, SC 13G 14, DEF 14A 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=XBIT (0.002 USD), /gw/filings/filings?ticker=XBIT&form=8-K, /gw/filings/facts?ticker=XBIT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange